drugset / Trial / NCT03998488

Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis

NCT03998488

RandomizedCrossoverTriple-blindTreatment

Summary

A double-blind, randomized, placebo-controlled clinical trial examining the efficacy and safety of Fecal Microbiota Transplantation (FMT) and high fiber supplementation in patients with active mild to moderate Ulcerative Colitis (UC). All enrolled subjects will provide serological, stool and mucosal specimen at each clinic visit to help further define the alterations in microbial profiles and immune cell function in response to psyllium fiber after FMT treatment.

Timeline

Start
2020-01-31
Primary completion
2023-06-09
Completion
2024-04-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ornidazole Other / unclassified 250 ml Other

Indications